Results 111 to 120 of about 8,401,904 (201)

Dual hemostatic defects in Glanzmann thrombasthenia and von Willebrand disease: functional characterization of ITGA2B and dominant-negative von Willebrand factor variants. [PDF]

Res Pract Thromb Haemost
Zhang Y, Shima T, Yamanaka I, Ueda S, Nishida A, Ohga S, Morodomi Y, Numata A, Eto T, Kanaji T, Okamura T, Kato K, Akashi K, Kunisaki Y, Kanaji S.   +14 more
europepmc   +1 more source

Immunocytochemical staining for lymphatic and blood vessels with frozen sections: using LYVE-1 for lymphatic vessel and von Willebrand factor for blood vessel marker. [PDF]

Eur J Histochem
Tomita T, Mah K.
europepmc   +1 more source

Recombinant von Willebrand factor for von Willebrand disease: mechanism of action and clinical application. [PDF]

Ther Adv Hematol
Hua Z, Miao W, Zhang P, Yang R.
europepmc   +1 more source

Reversible formation of von-Willebrand-factor-platelet aggregates in microvascular blood flow. [PDF]

PNAS Nexus
Topuz A, Hoore M, Gompper G, Fedosov DA.
europepmc   +1 more source

Retrospective study of multimers in von Willebrand disease

reservedIl fattore von Willebrand (VWF) è una glicoproteina multimerica essenziale per l’emostasi primaria, con i multimeri ad alto peso molecolare (HMWM) particolarmente cruciali per la corretta funzione emostatica.
SIMONI, ELENA
core  

Identification of von Willebrand Factor-Enriched Small Extracellular Vesicles as a Blood-Based Biomarker for the Detection of Head and Neck Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Su Y, Visan KS, Ham S, Li X, Park SH, Ng CWK, Yam JWP, Chan JYK, Möller A.   +8 more
europepmc   +1 more source

von Willebrand Factor fibers formed at pathological high shear provide a scaffold for α-synuclein binding and aggregation. [PDF]

Sci Rep
Rossi JM, Diamond SL.
europepmc   +1 more source

Von Willebrand Factor and ADAMTS13 in Relation to Major Adverse Limb Events in Peripheral Artery Disease. [PDF]

Vasc Specialist Int
Agid N, Andrisani P, Khan H, Qadura M, Kretz CA, Bhagirath VC.   +5 more
europepmc   +1 more source

Flow molecular dynamics simulations reveal mechano-presentation of von Willebrand factor through glycan-modulated autoinhibitory modules. [PDF]

APL Bioeng
Louis NELR, Zhao YC, Ju LA.
europepmc   +1 more source

Von Willebrand factor A2 domain inhibits A1-DNA binding while preserving A1-platelet interaction under flow: evidence from recombinant domain constructs. [PDF]

Res Pract Thromb Haemost
Peng Z, Sun X, Qu G, Fang J, Liu A, Huang Y, Wu Z, Yang J, Ma J, Lin J.   +9 more
europepmc   +1 more source